Search - tctmd.com

Displaying 581 - 600 of 4642

Sort: Relevancy | Date

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Caitlin E. Cox

November 03, 2023

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

News Conference News TCT 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Todd Neale

October 26, 2023

News Conference News TCT 2023

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Todd Neale

October 26, 2023

News Conference News TCT 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Caitlin E. Cox

October 26, 2023

Presentation TCT 2023

TCT 753: Development of a Machine Learning Based Futility Risk Model to Predict One Year Mortality in Transcatheter Aortic Valve Replacement

Presenter: APURVA BHARUCHA

October 26, 2023

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

Presentation TCT 2023

TCT 558: Clinical Outcome and Mortality of Catheter-interventional Treatment Options in high-risk Pulmonary Artery Embolism

Presenter: Luise Mentzel

October 24, 2023

Presentation TCT 2023

TCT 294: Comparrison of Predicted to Observed Mortality in High Risk Pulmonary Embolism Patients Undergoing Thrombectomy

Presenter: Hassan Saleh

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Advertisement

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

TCTMD’s Top 10 Most Popular Stories for October 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

TCT 753: Development of a Machine Learning Based Futility Risk Model to Predict One Year Mortality in Transcatheter Aortic Valve Replacement

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

TCT 558: Clinical Outcome and Mortality of Catheter-interventional Treatment Options in high-risk Pulmonary Artery Embolism

TCT 294: Comparrison of Predicted to Observed Mortality in High Risk Pulmonary Embolism Patients Undergoing Thrombectomy

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content